Coronary heart disease is the single leading cause of death in Australia. Cardiovascular disease (CVD) is responsible for almost a third of all deaths.1,2 Statins remain the cornerstone of CVD prevention through their lipid lowering effects and significant impact on major cardiovascular events and mortality.3
After successful completion of this CPD activity, pharmacists should be able to:
Competency standards addressed (2016): 1.1, 1.5, 2.2, 3.5
Accreditation number: CAP1911CAMNR
Already read the CPD in the journal? Scroll to the bottom to SUBMIT ANSWERS.
Statin intolerance, particularly muscle related adverse effects (statin related muscular symptoms or SAMS), are the leading cause of statin discontinuation.4 Identifying true SAMS involves taking a detailed patient history; assessing the nature and timing of the muscle symptoms, and measuring any associated elevations in creatine kinase.5 Up to two in three Australians use comp
THIS IS A CPD ARTICLE. YOU NEED TO BE A PSA MEMBER AND LOGGED IN TO READ MORE.